25 results on '"Durkin M"'
Search Results
2. PDB26 ESTIMATED RENAL AND CARDIOVASCULAR OUTCOMES AND COST OFFSETS IN PATIENTS WITH TYPE 2 DIABETES (T2D) AND DIABETIC NEPHROPATHY (DKD) TREATED WITH CANAGLIFLOZIN
3. Cybersecurity in Healthcare: Comparing Cybersecurity Maturity and Experiences Across Global Healthcare Organizations
4. PDB38 REAL-WORLD COMPARISON OF HOSPITALIZATION COSTS FOR HEART FAILURE IN T2DM PATIENTS WITH CARDIOVASCULAR DISEASE TREATED WITH CANAGLIFLOZIN VERSUS OTHER ANTIHYPERGLYCEMIC AGENTS
5. Characterization of Patient Activation, Clinical Assessments, and Patient Reported Outcomes in T2DM Patients
6. The Long-Term Benefits of Ensuring Timely Treatment and Improved Medication Adherence in Early Schizophrenia: A Microsimulation Study
7. Assessing the impact of varying threshold criteria for Opioid Overutilization
8. Streamlining the diagnosis of autism spectrum disorder for the National Children's Study
9. An Evaluation Of Opioid Overutilization Quality Metrics Using Receiver Operating Characteristic Curves And Proxies For Overutilization
10. Factors associated with performance on the medicaid hedis measure: Continuity of antipsychotic (AP) medications for treatment of schizophrenia
11. The majority of variance in birthweight relative to placental weight (as beta=ln(PW)/ln(BW) is accounted for by detailed novel placental measures: implications for fetal origins work
12. PMH84 Validity of Administrative Claims Data for Calculating Adherence Measures for Long-Acting Injectable (Lai) Antipsychotic Therapies
13. PMH51 Attributes Associated with a Preference for Monthly Injectable Therapy in Patients with Schizophrenia
14. Should we, in the UK, be taking vitamin D supplements during the winter?
15. PMH85 PATTERNS OF AUGMENTATION OF EXTENDED-RELEASE STIMULANTS FOR ADHD WITH IMMEDIATE-RELEASE STIMULANTS IN CHILDREN AND ADOLESCENTS
16. PMH82 PATTERNS OF AUGMENTATION OF EXTENDED-RELEASE STIMULANTS FOR ADHD WITH IMMEDIATE-RELEASE STIMULANTS IN ADULTS
17. MH3 PREVALENCE OF LIVER DISEASES IN MEDICAID RECIPIENTS WITH SCHIZOPHRENIA
18. PGI3 IMPACT OF PROTON PUMP INHIBITOR UTILIZATION PATTERNS ON GASTROESOPHAGEAL REFLUX DISEASE-RELATED COSTS
19. PMH26 A COMPARISON OF RISPERIDONE AND OLANZAPINE MENTAL HEALTH COSTS FOR MANAGED CARE PATIENTS WITH SCHIZOPHRENIA
20. PNP4 PRESCRIBING PATTERNS OF LONG-ACTING OPIOIDS FOR CHRONIC NON-MALIGNANT PAIN IN THE VETERANS ADMINISTRATION SYSTEM
21. PNP14: COST AND UTILIZATION OUTCOMES OF PATIENTS TREATED FOR SCHIZOPHRENIA IN A MEDICAID POPULATION
22. Book Review
23. EFFECT OF Paco ON CEREBRAL BLOOD FLOW DISTRIBUTION DURING HALOTHANE COMPARED WITH ISOFLURANE ANAESTHESIA IN THE RAT
24. Characterization of the basement membrane glycoprotein entactin synthesized in a baculovirus expression system.
25. Synthesis of laminin and entactin by F9 cells induced with retinoic acid and dibutyryl cyclic AMP.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.